Mustansar Abbas

Mustansar Abbas

Auto-generated profile, based on publicly available information

Mustansar Abbas

Centre for Nanosciences, University of Okara, Okara 56130, Pakistan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2023
Verified
Journal Article
Open access
MKMisbah Ullah Khan
Misbah Ullah Khan
HUHayat Ullah
Hayat Ullah
SHShehla Honey
Shehla Honey
ZTZunaira Talib
Zunaira Talib
MAMustansar Abbas
Mustansar Abbas
JAJamil Asim
Jamil Asim
The study of nanoparticles has grown in significance during the last several years. Nanoparticles are a kind of material that is composed of very tiny particles. Nanoparticle characteristics vary greatly depending on their size and form. The surface of a nanoparticle significantly affects its optical, mechanical, magnetic, and other characteristics. Nanoparticles are categorised according to their size, origin and chemical composition. We created nanoparticles using both top-down and bottom-up techniques. In this article, we discuss various different methods for creating nanomaterials, such as sol-gel processes, gas condensation, vacuum deposition and vaporisation, chemical vapour deposition and condensate, mechanical attrition, chemical precipitation, electrodeposition, and chemical vapour condensation. When it comes to creating nanoparticles, green synthesis is one of the most effective approaches. In this article, we explore eco-friendly techniques for manufacturing alloy nanoparticles, silver, gold, silver oxide and silver sulphide. We also explore the process by which microorganisms in this setting produce nanoparticles. Size and form must be maintained under certain conditions. We consider ways in which to enhance the production of nanoparticles in the future. The risks posed by nanoparticles and the ways in which to mitigate them were also taken into account.

13 December 2024
Verified
Journal Article
Open access
PDF file
HAHumaira Aslam
Humaira Aslam
AUAli Umar
Ali Umar
NNNazia Nusrat
Nazia Nusrat
MMManel Mansour
Manel Mansour
AUAman Ullah
Aman Ullah
MKMisbah Ullah Khan
Misbah Ullah Khan
Nanoparticles (NPs) are at the forefront as they are providing unprecedented solutions to obstacles and issues in treating neurodegenerative diseases. Due to their size, surface characteristics, and ability to be functionalized, these carriers can directly deliver therapeutics across what is considered one of the main barriers to central nervous system (CNS) treatment, the blood-brain barrier (BBB). Through nano-technology, anti-disease agents such as Alzheimer’s, Parkinson’s, and Huntington’s therapies become more bioavailable, specific in action, and with fewer side effects. The NPs serve as molecular carriers that facilitate transport across the BBB by receptor-mediated transcytosis or by disruption of the barrier with a view to properly delivering drugs to the neural tissues. Some of the therapeutic applications of nanotechnology also present the concept of molecular medicine since the NPs are designed to deliver drugs in accordance with specific biomolecule signals. Besides the therapeutic applications, NPs replace the traditional contrast media for magnetic resonance imaging (MRI) and positron emission tomography (PET) scans for better diagnosis as well as disease tracking in the early stages. In addition, their effects on solubility increase the therapeutic potential of earlier useless compounds, and the preservation of bioactive molecules from degradation increases the therapeutic capacity of medications. Neurodegenerative disorders are marked by oxidative stress and inflammation that contribute to the disease severity; thus, liposomes, dendrimers, and polymeric NPs encapsulate antioxidants and anti-inflammatory compounds, so they target the areas most affected by the disease. Such sophisticated systems minimize the extension of neuronal deterioration and enhance the lot of such patients. The “theranostic” NPs allow for continuous diagnosis and treatment by containing both diagnostic and therapeutic features. These have created unprecedented opportunities to meet the unmet needs in CNS disorders and may revolutionize the evolution of managing neurodegenerative diseases and innovative neuroimaging procedures in the future.

13 December 2024
Verified
Journal Article
Closed access
HAHumaira Aslam
Humaira Aslam
NNNazia Nusrat
Nazia Nusrat
MMManel Mansour
Manel Mansour
AUAli Umar
Ali Umar
AUAman Ullah
Aman Ullah
MKMisbah Ullah Khan
Misbah Ullah Khan
Silver iodide (AgI) nanostructures have been considered as promising candidates for optical biosensors owing to their optical characteristics of optical properties, including tunable surface plasmon resonance (SPR) and fluorescence enhancement. Such properties let one analyze biomolecules with high sensitivity, which makes them ultra-useful in diagnostics. The formed AgI nanostructures can be synthesized using chemical precipitation and template methods that enable fine-tuning of the morphology and crystallinity of the final nanostructure. The presence of SPR enhances optical signals potentially, and fluorescence enhancement helps visualize biomolecule interactions easier as the analyte concentration is usually low. Such uses of biosensors include applications in proteins, nucleic acids, and other biomolecules for progress in disease diagnosis and pharmacogenomics. Moreover, the good biocompatibility level of the created AgI nanostructures makes it possible to integrate them into biological systems safely, increasing their usage in medicine. This integration of their appealing optics, biosensing operating principles, and biocompatibility establishes their centrality in the creation of future photonic biosensors for faster, intuitive, and painless detection.